Zoetis cuts 2026 guidance as second-quarter revenue stays flat at $2.5 billion
Zoetis reported flat second-quarter 2026 revenue of $2.5 billion and net income of $691 million, or $1.65 per diluted share, up 1% on a reported basis. The company also cut its full-year 2026 guidance: revenue is now $9.120 billion to $9.320 billion, down from $9.680 billion to $9.960 billion, and adjusted diluted EPS is now $6.15 to $6.25, down from $6.85 to $7.00. The cut reflects a weaker Companion Animal market, which the company said was affected by lower clinic visits, pet owner price sensitivity and heightened competition.
Key points
- Q2 2026 revenue was $2.5 billion, flat versus Q2 2025; U.S. segment revenue fell 7% while International rose 8% on a reported basis.
- Q2 2026 adjusted net income was $781 million, or $1.87 per diluted share, down 1% and up 5% respectively on a reported basis.
- Full-year 2026 revenue guidance was revised to $9.120 billion to $9.320 billion, organic operational growth of (3)% to (1)%, versus prior guidance of 2% to 5%.
- Full-year 2026 adjusted diluted EPS guidance was revised to $6.15 to $6.25, down from $6.85 to $7.00; reported diluted EPS guidance is $5.55 to $5.65.
The filing
Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.